SINAGRA, Gianfranco
 Distribuzione geografica
Continente #
NA - Nord America 1.772
AS - Asia 1.321
EU - Europa 789
SA - Sud America 342
AF - Africa 31
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.262
Nazione #
US - Stati Uniti d'America 1.706
SG - Singapore 472
CN - Cina 348
BR - Brasile 305
HK - Hong Kong 249
IT - Italia 165
DE - Germania 155
FI - Finlandia 107
UA - Ucraina 74
RU - Federazione Russa 72
GB - Regno Unito 64
TR - Turchia 59
VN - Vietnam 50
CA - Canada 36
IN - India 36
IE - Irlanda 34
BD - Bangladesh 32
FR - Francia 22
JP - Giappone 20
MX - Messico 18
PL - Polonia 15
SE - Svezia 15
ES - Italia 13
ZA - Sudafrica 12
AT - Austria 11
AR - Argentina 10
CZ - Repubblica Ceca 10
IQ - Iraq 10
EC - Ecuador 8
MA - Marocco 8
SA - Arabia Saudita 8
NL - Olanda 7
LT - Lituania 6
UZ - Uzbekistan 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
PK - Pakistan 5
BG - Bulgaria 4
KE - Kenya 4
AZ - Azerbaigian 3
BE - Belgio 3
BO - Bolivia 3
CH - Svizzera 3
CO - Colombia 3
EG - Egitto 3
JO - Giordania 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
PA - Panama 3
PH - Filippine 3
PY - Paraguay 3
CR - Costa Rica 2
GR - Grecia 2
JM - Giamaica 2
LV - Lettonia 2
PE - Perù 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
CL - Cile 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
HN - Honduras 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
PS - Palestinian Territory 1
RO - Romania 1
RW - Ruanda 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
Totale 4.262
Città #
Hong Kong 248
Ashburn 231
Singapore 187
Beijing 144
Fairfield 110
New York 86
Helsinki 77
Los Angeles 74
Dallas 66
Woodbridge 66
Chandler 57
Jacksonville 56
Munich 55
Istanbul 54
Seattle 53
Wilmington 44
Houston 40
Princeton 40
Cambridge 37
Dublin 34
São Paulo 33
Buffalo 27
Romola 27
Redondo Beach 26
Ann Arbor 25
San Francisco 24
Moscow 23
Shanghai 23
Chicago 19
Milan 19
Brescia 18
Ho Chi Minh City 18
Turku 18
Montreal 17
Tokyo 17
Washington 17
Nanjing 16
Frankfurt am Main 15
Santa Clara 15
The Dalles 15
Hanoi 14
London 13
Warsaw 13
Boston 12
Atlanta 11
Nuremberg 11
Chennai 10
Dearborn 10
Lappeenranta 10
Orem 10
Rome 10
Stockholm 10
Belo Horizonte 9
Brno 9
Guangzhou 9
Poplar 9
Brooklyn 8
Denver 8
Hebei 8
Rio de Janeiro 8
San Diego 8
Toronto 8
Boydton 7
Des Moines 7
Düsseldorf 7
Johannesburg 7
Salvador 7
Vienna 7
City of London 6
Curitiba 6
Novara 6
Phoenix 6
Brasília 5
Charlotte 5
Hangzhou 5
Jinan 5
Pune 5
Shenyang 5
Tashkent 5
Colombo 4
Dammam 4
Dhaka 4
Juneau 4
Leipzig 4
Mumbai 4
Nairobi 4
Portsmouth 4
Querétaro 4
Santo André 4
Sete Lagoas 4
Tianjin 4
Venice 4
Amman 3
Ankara 3
Baghdad 3
Baku 3
Brussels 3
Campina Grande 3
Campinas 3
Campos dos Goytacazes 3
Totale 2.566
Nome #
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 141
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 129
Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group 128
Heart failure and anemia: Effects on prognostic variables 126
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 125
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation 123
The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 117
ANMCO / FADOI / SIAARTI / SIC / SIMG / SIMI / SIMEU Consensus Document: The clinical-diagnostic and therapeutic pathway of the patient with acute heart failure from home to discharge from the Emergency Room / Emergency Department-Acceptance 101
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) 93
[Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system (RAAS) blockade in heart failure patients - Part I: From RAAS identification to clinical trials] 85
Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying Approach 84
The prognostic value of serial troponin measurements in patients admitted for COVID-19 83
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 80
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 79
[Palliative inotrope therapy in advanced heart failure: organization and management] 79
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 75
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part II: From preventive strategies to treatment of patients with cardio-renal damage] 74
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part I: From cardiovascular risk factors to the mechanisms of cardio-renal syndrome] 73
[Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system blockade in heart failure patients - Part II: Mechanistic effects of sacubitril/valsartan, placement in current guidelines and use in clinical practice] 73
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study 72
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation 72
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 70
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 70
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 69
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 68
[Transcatheter devices for chronic heart failure: state of the art] 68
Atrial signal amplitude predicts atrial high-rate episodes in implantable cardioverter defibrillator patients: Insights from a large database of remote monitoring trasmissions 68
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 67
[Myocarditis and pericarditis following mRNA COVID-19 vaccination. Expert opinion of the Italian Society of Cardiology] 64
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era 64
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 62
[2022 Update on myocarditis and pericarditis following COVID-19 vaccination. Expert Opinion of the Italian Society of Cardiology] 61
[Italian Society of Cardiology (SIC) Position paper: Technical, instrumental and standards of interpretation for electrocardiography, ambulatory electrocardiographic and blood pressure monitoring in telemedicine] 59
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 54
Value of the HFA-PEFF and H2 FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 53
Frailty according to the 2019 HFA-ESC definition in patients at risk for advanced heart failure: Insights from the HELP-HF registry 53
Palliative care in the cardiac setting: A consensus document of the Italian Society of Cardiology (SIC) and Italian Society of Palliative Care (SICP) Joint Working Group 53
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry 52
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 50
[Italian Society of Cardiology (SIC) Expert consensus document: Post-acute cardiovascular sequelae of SARS-CoV-2 infection] 50
The impact of UEFA Euro 2020 football championship on Takotsubo Syndrome: Results of a multicenter national registry 50
Apoptosis, a useful marker in the management of hot-phase cardiomyopathy? 49
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 49
Effects of the COVID-19 pandemic on the formation of fellows in training in cardiology 48
Impact of malnutrition in patients with severe heart failure 48
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 48
Predicting survival in patients with severe heart failure: Risk score validation in the HELP-HF cohort 48
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 48
Ischemic Etiology in Advanced Heart Failure: Insight from the HELP-HF Registry 48
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 47
Correction to: SARS‑CoV‑2, myocardial injury and inflammation: insights from a large clinical and autopsy study 46
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 46
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry 45
The chronic heart failure evolutions: Different fates and routes 45
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 45
Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: an analysis from the HELP-HF registry 44
Management of hypertrophic cardiomyopathy 43
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes. Data from the Swedish Heart Failure and Swedish National Diabetes Registries 42
Clinical Phenotype and Prognosis of Asymptomatic Patients With Transthyretin Cardiac Amyloid Infiltration 38
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 37
Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of Cardiology 36
Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype 36
Outcome and Morphofunctional Changes on Cardiac Magnetic Resonance in Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination 34
Role of ejection fraction in patients at risk for advanced heart failure: insights from the HELP-HF registry 33
SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study 33
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy 29
Aetiological phenotypes of atrial and ventricular secondary tricuspid regurgitation and their prognostic implications: insights from the CARE-TR registry 26
Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension 21
Totale 4.329
Categoria #
all - tutte 30.233
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.233


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021142 0 0 0 0 15 18 3 28 16 31 16 15
2021/2022123 6 5 5 9 1 5 1 9 7 16 19 40
2022/2023238 37 23 4 4 11 52 2 23 51 3 14 14
2023/2024637 35 13 68 60 43 111 39 23 111 25 26 83
2024/20251.317 15 12 43 144 97 100 173 69 120 91 248 205
2025/20261.398 270 387 205 390 146 0 0 0 0 0 0 0
Totale 4.329